{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:44:57Z","timestamp":1790621097816,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T00:00:00Z","timestamp":1469750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T00:00:00Z","timestamp":1469750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Artemisinin resistance in<jats:italic>Plasmodium falciparum<\/jats:italic>threatens global efforts in the elimination or eradication of malaria. Several studies have associated mutations in the<jats:italic>PfATP6<\/jats:italic>gene in conjunction with artemisinin resistance, but the underlying molecular mechanism of the resistance remains unexplored. Associated mutations act as a biomarker to measure the artemisinin efficacy. In the proposed work, we have analyzed the binding affinity and efficacy between PfATP6 and artemisinin in the presence of L263D, L263E and L263K mutations. Furthermore, we performed virtual screening to identify potential compounds to inhibit the PfATP6 mutant proteins. In this study, we observed that artemisinin binding affinity with PfATP6 gets affected by L263D, L263E and L263K mutations. This<jats:italic>in silico<\/jats:italic>elucidation of artemisinin resistance enhanced the identification of novel compounds (CID: 10595058 and 10625452) which showed good binding affinity and efficacy with L263D, L263E and L263K mutant proteins in molecular docking and molecular dynamics simulations studies. Owing to the high propensity of the parasite to drug resistance the need for new antimalarial drugs will persist until the malarial parasites are eventually eradicated. The two compounds identified in this study can be tested in<jats:italic>in vitro<\/jats:italic>and<jats:italic>in vivo<\/jats:italic>experiments as possible candidates for the designing of new potential antimalarial drugs.<\/jats:p>","DOI":"10.1038\/srep30106","type":"journal-article","created":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T10:24:30Z","timestamp":1469787870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Mechanism of artemisinin resistance for malaria PfATP6 L263 mutations and discovering potential antimalarials: An integrated computational approach"],"prefix":"10.1038","volume":"6","author":[{"given":"Nagasundaram","family":"N.","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Priya Doss","family":"C.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiranjib","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthick","family":"V.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thirumal Kumar","family":"D.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaji","family":"V.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siva","family":"R.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,29]]},"reference":[{"key":"BFsrep30106_CR1","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1126\/science.3887571","volume":"228","author":"DL Klayman","year":"1985","unstructured":"Klayman, D. L. Qinghaosu (artemisinin): an antimalarial drug from China. Science 228, 1049\u20131055 (1985).","journal-title":"Science"},{"key":"BFsrep30106_CR2","doi-asserted-by":"crossref","unstructured":"Arrow, K. J., Panosian, C. B. & Geltband, H. Saving Lives, Buying Time. (National Academies Press), doi: 10.17226\/11017 (2004).","DOI":"10.17226\/11017"},{"key":"BFsrep30106_CR3","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.2174\/0929867013371608","volume":"8","author":"CW Jefford","year":"2001","unstructured":"Jefford, C. W. Why artemisinin and certain synthetic peroxides are potent antimalarials. Implications for the mode of action. Curr. Med. Chem. 8, 1803\u20131826 (2001).","journal-title":"Curr. Med. Chem."},{"key":"BFsrep30106_CR4","doi-asserted-by":"publisher","first-page":"19383","DOI":"10.1074\/jbc.274.27.19383","volume":"274","author":"AV Pandey","year":"1999","unstructured":"Pandey, A. V., Tekwani, B. L., Singh, R. L. & Chauhan, V. S. Artemisinin, an endoperoxide antimalarial, disrupts the hemoglobin catabolism and heme detoxification systems in malarial parasite. J. Biol. Chem. 274, 19383\u201319388 (1999).","journal-title":"J. Biol. Chem."},{"key":"BFsrep30106_CR5","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1080\/00034983.1985.11811933","volume":"79","author":"DS Ellis","year":"1985","unstructured":"Ellis, D. S. et al. The chemotherapy of rodent malaria, XXXIX. Ultrastructural changes following treatment with artemisinine of Plasmodium berghei infection in mice, with observations of the localization of [3H]-dihydroartemisinine in P. falciparum in vitro. Ann. Trop. Med. Parasitol. 79, 367\u2013374 (1985).","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"BFsrep30106_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1006\/expr.1993.1010","volume":"76","author":"F Ter Kuile","year":"1993","unstructured":"Ter Kuile, F., White, N. J., Holloway, P., Pasvol, G. & Krishna, S. Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria. Exp. Parasitol. 76, 85\u201395 (1993).","journal-title":"Exp. Parasitol."},{"key":"BFsrep30106_CR7","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/nature01813","volume":"424","author":"U Eckstein-Ludwig","year":"2003","unstructured":"Eckstein-Ludwig, U. et al. Artemisinins target the SERCA of Plasmodium falciparum. Nature 424, 957\u2013961 (2003).","journal-title":"Nature"},{"key":"BFsrep30106_CR8","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1056\/NEJMc0805011","volume":"359","author":"H Noedl","year":"2008","unstructured":"Noedl, H. et al. Evidence of artemisinin-resistant malaria in western Cambodia. N. Engl. J. Med. 359, 2619\u20132620 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFsrep30106_CR9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp, A. M. et al. Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 361, 455\u2013467 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFsrep30106_CR10","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1073\/pnas.1006113108","volume":"108","author":"S Saralamba","year":"2011","unstructured":"Saralamba, S. et al. Intrahost modeling of artemisinin resistance in Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 108, 397\u2013402 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFsrep30106_CR11","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1128\/AAC.01868-12","volume":"57","author":"B Witkowski","year":"2013","unstructured":"Witkowski, B. et al. Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western Cambodia. Antimicrob. Agents Chemother. 57, 914\u2013923 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFsrep30106_CR12","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/1471-2164-12-391","volume":"12","author":"S Mok","year":"2011","unstructured":"Mok, S. et al. Artemisinin resistance in Plasmodium falciparum is associated with an altered temporal pattern of transcription. BMC Genomics 12, 391 (2011).","journal-title":"BMC Genomics"},{"key":"BFsrep30106_CR13","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/S1473-3099(13)70252-4","volume":"13","author":"B Witkowski","year":"2013","unstructured":"Witkowski, B. et al. Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies. Lancet. Infect. Dis. 13, 1043\u20131049 (2013).","journal-title":"Lancet. Infect. Dis."},{"key":"BFsrep30106_CR14","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1128\/AAC.01924-13","volume":"58","author":"K Chotivanich","year":"2014","unstructured":"Chotivanich, K. et al. Laboratory detection of artemisinin-resistant Plasmodium falciparum. Antimicrob. Agents Chemother. 58, 3157\u20133161 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFsrep30106_CR15","unstructured":"World Health Organization Global Malaria Programme. Status report on artemisinin resistance. WHO\/HTM\/GMP\/20149, 2014. Geneva: The Organization (2014)."},{"key":"BFsrep30106_CR16","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/S0140-6736(12)60484-X","volume":"379","author":"AP Phyo","year":"2012","unstructured":"Phyo, A. P. et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet (London, England) 379, 1960\u20131966 (2012).","journal-title":"Lancet (London, England)"},{"key":"BFsrep30106_CR17","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S1473-3099(12)70181-0","volume":"12","author":"C Amaratunga","year":"2012","unstructured":"Amaratunga, C. et al. Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. Lancet. Infect. Dis. 12, 851\u2013858 (2012).","journal-title":"Lancet. Infect. Dis."},{"key":"BFsrep30106_CR18","doi-asserted-by":"publisher","first-page":"e57689","DOI":"10.1371\/journal.pone.0057689","volume":"8","author":"MP Kyaw","year":"2013","unstructured":"Kyaw, M. P. et al. Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar. PLoS One 8, e57689 (2013).","journal-title":"PLoS One"},{"key":"BFsrep30106_CR19","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/1475-2875-11-355","volume":"11","author":"TT Hien","year":"2012","unstructured":"Hien, T. T. et al. In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam. Malar. J. 11, 355 (2012).","journal-title":"Malar. J."},{"key":"BFsrep30106_CR20","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/nsmb947","volume":"12","author":"AC Uhlemann","year":"2005","unstructured":"Uhlemann, A. C. et al. A single amino acid residue can determine the sensitivity of SERCAs to artemisinins. Nat. Struct. Mol. Biol. 12, 628\u2013629 (2005).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"BFsrep30106_CR21","doi-asserted-by":"publisher","first-page":"e1000887","DOI":"10.1371\/journal.ppat.1000887","volume":"6","author":"SG Valderramos","year":"2010","unstructured":"Valderramos, S. G. et al. Identification of a mutant PfCRT-mediated chloroquine tolerance phenotype in Plasmodium falciparum. PLoS Pathog. 6, e1000887 (2010).","journal-title":"PLoS Pathog."},{"key":"BFsrep30106_CR22","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1142\/S021972000700320X","volume":"5","author":"YL Yip","year":"2007","unstructured":"Yip, Y. L., Lachenal, N., Pillet, V. & Veuthey, A.-L. Retrieving mutation-specific information for human proteins in UniProt\/Swiss-Prot Knowledgebase. J. Bioinform. Comput. Biol. 5, 1215\u20131231 (2007).","journal-title":"J. Bioinform. Comput. Biol"},{"key":"BFsrep30106_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jsb.2012.02.008","volume":"178","author":"R Sacchetto","year":"2012","unstructured":"Sacchetto, R. et al. Crystal structure of sarcoplasmic reticulum Ca2+-ATPase (SERCA) from bovine muscle. J. Struct. Biol. 178, 38\u201344 (2012).","journal-title":"J. Struct. Biol."},{"key":"BFsrep30106_CR24","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1016\/j.bmcl.2005.04.041","volume":"15","author":"M Jung","year":"2005","unstructured":"Jung, M., Kim, H., Nam, K. Y. & No, K. T. Three-dimensional structure of Plasmodium falciparum Ca2+ -ATPase(PfATP6) and docking of artemisinin derivatives to PfATP6. Bioorg. Med. Chem. Lett. 15, 2994\u20132997 (2005).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"BFsrep30106_CR25","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00894-010-0726-4","volume":"17","author":"PK Naik","year":"2011","unstructured":"Naik, P. K. et al. The binding modes and binding affinities of artemisinin derivatives with Plasmodium falciparum Ca2+-ATPase (PfATP6). J. Mol. Model. 17, 333\u2013357 (2011).","journal-title":"J. Mol. Model."},{"key":"BFsrep30106_CR26","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1093\/bioinformatics\/btm404","volume":"23","author":"MA Larkin","year":"2007","unstructured":"Larkin, M. A. et al. Clustal W and Clustal X version 2.0. Bioinformatics 23, 2947\u20132948 (2007).","journal-title":"Bioinformatics"},{"key":"BFsrep30106_CR27","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","volume":"234","author":"A Sali","year":"1993","unstructured":"Sali, A. & Blundell, T. L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234, 779\u2013815 (1993).","journal-title":"J. Mol. Biol."},{"key":"BFsrep30106_CR28","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1110\/ps.9.9.1753","volume":"9","author":"A Fiser","year":"2000","unstructured":"Fiser, A., Do, R. K. & Sali, A. Modeling of loops in protein structures. Protein Sci. 9, 1753\u20131773 (2000).","journal-title":"Protein Sci."},{"key":"BFsrep30106_CR29","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1107\/S0021889892009944","volume":"26","author":"RA Laskowski","year":"1993","unstructured":"Laskowski, R. A., MacArthur, M. W., Moss, D. S. & Thornton, J. M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26, 283\u2013291 (1993).","journal-title":"J. Appl. Crystallogr"},{"key":"BFsrep30106_CR30","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nature01097","volume":"419","author":"MJ Gardner","year":"2002","unstructured":"Gardner, M. J. et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419, 498\u2013511 (2002).","journal-title":"Nature"},{"key":"BFsrep30106_CR31","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1002\/cmdc.200900200","volume":"4","author":"FBE Garah","year":"2009","unstructured":"Garah, F. B. E., Stigliani, J.-L., Cosledan, F., Meunier, B. & Robert, A. Docking studies of structurally diverse antimalarial drugs targeting PfATP6: no correlation between in silico binding affinity and in vitro antimalarial activity. ChemMedChem 4, 1469\u20131479 (2009).","journal-title":"ChemMedChem"},{"key":"BFsrep30106_CR32","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. J. Comput. Chem. 31, 455\u2013461 (2010).","journal-title":"J. Comput. Chem."},{"key":"BFsrep30106_CR33","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/35015017","volume":"405","author":"C Toyoshima","year":"2000","unstructured":"Toyoshima, C., Nakasako, M., Nomura, H. & Ogawa, H. Crystal structure of the calcium pump of sarcoplasmic reticulum at 2.6 A resolution. Nature 405, 647\u2013655 (2000).","journal-title":"Nature"},{"key":"BFsrep30106_CR34","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/nature00944","volume":"418","author":"C Toyoshima","year":"2002","unstructured":"Toyoshima, C. & Nomura, H. Structural changes in the calcium pump accompanying the dissociation of calcium. Nature 418, 605\u2013611 (2002).","journal-title":"Nature"},{"key":"BFsrep30106_CR35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0006-3495(98)77493-4","volume":"75","author":"H Ogawa","year":"1998","unstructured":"Ogawa, H., Stokes, D. L., Sasabe, H. & Toyoshima, C. Structure of the Ca2+ pump of sarcoplasmic reticulum: a view along the lipid bilayer at 9-A resolution. Biophys. J. 75, 41\u201352 (1998).","journal-title":"Biophys. J."},{"key":"BFsrep30106_CR36","doi-asserted-by":"publisher","first-page":"8461","DOI":"10.1021\/jm101020z","volume":"53","author":"P Ripphausen","year":"2010","unstructured":"Ripphausen, P., Nisius, B., Peltason, L. & Bajorath, J. Quo vadis, virtual screening? A comprehensive survey of prospective applications. J. Med. Chem. 53, 8461\u20138467 (2010).","journal-title":"J. Med. Chem."},{"key":"BFsrep30106_CR37","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1517\/17460441.3.8.841","volume":"3","author":"DE Clark","year":"2008","unstructured":"Clark, D. E. What has virtual screening ever done for drug discovery? Expert Opin. Drug Discov. 3, 841\u2013851 (2008).","journal-title":"Expert Opin. Drug Discov"},{"key":"BFsrep30106_CR38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1208\/s12248-012-9322-0","volume":"14","author":"T Cheng","year":"2012","unstructured":"Cheng, T., Li, Q., Zhou, Z., Wang, Y. & Bryant, S. H. Structure-based virtual screening for drug discovery: a problem-centric review. AAPS J. 14, 133\u2013141 (2012).","journal-title":"AAPS J."},{"key":"BFsrep30106_CR39","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/157340911795677602","volume":"7","author":"XY Meng","year":"2011","unstructured":"Meng, X. Y., Zhang, H. X., Mezei, M. & Cui, M. Molecular docking: a powerful approach for structure-based drug discovery. Curr. Comput. Aided. Drug Des. 7, 146\u2013157 (2011).","journal-title":"Curr. Comput. Aided. Drug Des"},{"key":"BFsrep30106_CR40","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1074-5521(97)90069-7","volume":"4","author":"JA Gerlt","year":"1997","unstructured":"Gerlt, J. A., Kreevoy, M. M., Cleland, W. W. & Frey, P. A. Understanding enzymic catalysis: the importance of short, strong hydrogen bonds. Chem. Biol. 4, 259\u2013267 (1997).","journal-title":"Chem. Biol."},{"key":"BFsrep30106_CR41","doi-asserted-by":"publisher","first-page":"4400","DOI":"10.1073\/pnas.1015762108","volume":"108","author":"SA Charman","year":"2011","unstructured":"Charman, S. A. et al. Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria. Proc. Natl. Acad. Sci. USA 108, 4400\u20134405 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFsrep30106_CR42","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1126\/science.1193225","volume":"329","author":"M Rottmann","year":"2010","unstructured":"Rottmann, M. et al. Spiroindolones, a potent compound class for the treatment of malaria. Science 329, 1175\u20131180 (2010).","journal-title":"Science"},{"key":"BFsrep30106_CR43","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.2217\/fmb.10.136","volume":"5","author":"IB M\u00fcller","year":"2010","unstructured":"M\u00fcller, I. B. & Hyde, J. E. Antimalarial drugs: modes of action and mechanisms of parasite resistance. Future Microbiol. 5, 1857\u20131873 (2010).","journal-title":"Future Microbiol."},{"key":"BFsrep30106_CR44","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1042\/bse0510137","volume":"51","author":"JM Sa","year":"2011","unstructured":"Sa, J. M., Chong, J. L. & Wellems, T. E. Malaria drug resistance: new observations and developments. Essays Biochem. 51, 137\u2013160 (2011).","journal-title":"Essays Biochem."},{"key":"BFsrep30106_CR45","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1002\/anie.200503071","volume":"45","author":"RK Haynes","year":"2006","unstructured":"Haynes, R. K. et al. Artemisone a highly active antimalarial drug of the artemisinin class. Angew. Chem. Int. Ed. Engl. 45, 2082\u20132088 (2006).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"BFsrep30106_CR46","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pt.2010.11.006","volume":"27","author":"XC Ding","year":"2011","unstructured":"Ding, X. C., Beck, H. P. & Raso, G. Plasmodium sensitivity to artemisinins: magic bullets hit elusive targets. Trends Parasitol. 27, 73\u201381 (2011).","journal-title":"Trends Parasitol."},{"key":"BFsrep30106_CR47","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1093\/nar\/25.17.3389","volume":"25","author":"SF Altschul","year":"1997","unstructured":"Altschul, S. F. et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25, 3389\u20133402 (1997).","journal-title":"Nucleic Acids Res."},{"key":"BFsrep30106_CR48","unstructured":"Gunsteren, W. F. van . Biomolecular Simulation: The GROMOS96 Manual and User Guide. (Biomos ; Zurich, (1996)."},{"key":"BFsrep30106_CR49","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1002\/jcc.20090","volume":"25","author":"C Oostenbrink","year":"2004","unstructured":"Oostenbrink, C., Villa, A., Mark, A. E. & van Gunsteren, W. F. A biomolecular force field based on the free enthalpy of hydration and solvation: the GROMOS force-field parameter sets 53A5 and 53A6. J. Comput. Chem. 25, 1656\u20131676 (2004).","journal-title":"J. Comput. Chem."},{"key":"BFsrep30106_CR50","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris, G. M. et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 30, 2785\u20132791 (2009).","journal-title":"J. Comput. Chem."},{"key":"BFsrep30106_CR51","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/ct700301q","volume":"4","author":"B Hess","year":"2008","unstructured":"Hess, B., Kutzner, C., van der Spoel, D. & Lindahl, E. GROMACS 4: Algorithms for Highly Efficient, Load-Balanced and Scalable Molecular Simulation. J. Chem. Theory Comput. 4, 435\u2013447 (2008).","journal-title":"J. Chem. Theory Comput."},{"key":"BFsrep30106_CR52","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","volume":"81","author":"HJC Berendsen","year":"1984","unstructured":"Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., DiNola, A. & Haak, J. R. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81, 3684 (1984).","journal-title":"J. Chem. Phys."},{"key":"BFsrep30106_CR53","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","volume":"18","author":"B Hess","year":"1997","unstructured":"Hess, B., Bekker, H., Berendsen, H. J. C. & Fraaije, J. G. E. M. LINCS: A linear constraint solver for molecular simulations. J. Comput. Chem. 18, 1463\u20131472 (1997).","journal-title":"J. Comput. Chem."},{"key":"BFsrep30106_CR54","doi-asserted-by":"publisher","first-page":"8577","DOI":"10.1063\/1.470117","volume":"103","author":"U Essmann","year":"1995","unstructured":"Essmann, U. et al. A smooth particle mesh Ewald method. J. Chem. Phys. 103, 8577 (1995).","journal-title":"J. Chem. Phys."},{"key":"BFsrep30106_CR55","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"D Van Der Spoel","year":"2005","unstructured":"Van Der Spoel, D. et al. GROMACS: fast, flexible and free. J. Comput. Chem. 26, 1701\u20131718 (2005).","journal-title":"J. Comput. Chem."},{"key":"BFsrep30106_CR56","unstructured":"Turner, P. J. XMGRACE, Version 5.1.19. Central for costal and Land-Margin Research; Oregon Graduate Institute of Science and Technology, Beaverton, ORE, USA (2005)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep30106","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep30106.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep30106.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T15:49:29Z","timestamp":1718725769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep30106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,29]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,9,30]]}},"alternative-id":["BFsrep30106"],"URL":"https:\/\/doi.org\/10.1038\/srep30106","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,29]]},"assertion":[{"value":"20 January 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30106"}}